Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

Bristol-Myers Squibb (BMS) building

Opdivo drives growth at BMS, but US sales slow down

Sales beginning to lose momentum despite new indications bringing in $1.3bn for Q4

- PMLiVE

NICE U-turn on Imbruvica sees the leukaemia therapy backed for NHS use

Institute reverses its initial verdict on Janssen's oncology treatment

Celgene building

Celgene pays $300m upfront for immunology start-up Delinia

Broadens its pipeline with autoimmune disease candidate due to start trials in 2018

- PMLiVE

The reality of real-world evidence

Despite a slow uptake of RWE, there is an increasing trend in the use of healthcare system data to inform clinical practice

- PMLiVE

AXON Communications boosts senior team

Sola Neunie, Simonetta Ballali and Andy Scott join

- PMLiVE

Takeda UK & Ireland appoints market access director

Peter Wheatley Price brings experience from GSK, Janssen and Boehringer Ingelheim

- PMLiVE

AbbVie takes anti-tau drug into phase II for Alzheimer’s

Also testing antibody in rare condition PSP, for which FDA has awarded fast-track designation

Actelion HQ Switzerland

J&J agrees $30bn deal to acquire Actelion

Swiss biotech to retain control of early-stage pipeline as J&J takes minority stake in R&D spin-out

Smart connections with a human touch

Simon Young, Director at Blue Latitude Health, discusses how advances in technology are influencing the future of the expert-patient relationship and why healthcare businesses must evaluate how best to support...

Blue Latitude Health

- PMLiVE

The digital race: Eight ways to get up-to-speed

The festive season is over, so why does analysis of pharma’s digital progress feel like a Christmas repeat of Groundhog Day? Here are eight ideas to stop next year feeling like...

- PMLiVE

GSK appoints president of global pharmaceuticals

Luke Miels joins from AstraZeneca

- PMLiVE

Bayer appoints president of Americas pharma business

Dr Carsten Brunn to lead operations across the US, Canada, Central and Latin America

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links